Evidence map›Paper›PMID 33675682›Full record

ArticleAmerican journal of human genetics2021

De novo structural mutation rates and gamete-of-origin biases revealed through genome sequencing of 2,396 families.

Jonathan R Belyeu, Harrison Brand, Harold Wang, Xuefang Zhao, Brent S Pedersen, Julie Feusier, Meenal Gupta, Thomas J Nicholas, Joseph Brown, Lisa Baird and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Comprehensive analysis ofmedRxiv : the preprint server for health sciences · 2026
    Article
  9. Article
  10. Article
  11. Limitations of serial cloning in mammals.Nature communications · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. De novo rare EMX2 variants lead to idiopathic hypogonadotropic hypogonadism.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Direct identification ofbioRxiv : the preprint server for biology · 2025
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Jonathan R BelyeuDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Harrison BrandCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02114, USA.
Harold WangCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02114, USA.
Xuefang ZhaoCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02114, USA.
Brent S PedersenDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Julie FeusierHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Meenal GuptaDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Thomas J NicholasDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Joseph BrownDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Lisa BairdDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Bernie DevlinDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Stephan J SandersDepartment of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.
Lynn B JordeDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA; Utah Center for Genetic Discovery, University of Utah, Salt Lake City, UT 84112, USA.
Michael E TalkowskiCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02114, USA. Electronic address: mtalkowski@mgh.harvard.edu.
Aaron R QuinlanDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA; Department of Biomedical Informatics, University of Utah, Salt Lake City, UT 84112, USA; Utah Center for Genetic Discovery, University of Utah, Salt Lake City, UT 84112, USA. Electronic address: aaronquinlan@gmail.com.
University of Utah · USMassachusetts General Hospital · USHarvard University · USStar Center · USUniversity of California, San Francisco · USUniversity of Pittsburgh · US

Funding

Clinical Diagnostic Sequencing of Structural VariationR01HD081256 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2015 to 2025
$7.2M
Scalable tool and comprehensive maps to interpret structural variation across the neuropsychiatric spectrumR01MH115957 · NIMH · BROAD INSTITUTE, INC. · PI TALKOWSKI, MICHAEL E · 2019 to 2025
$5.4M
Human Genetic Variation and DiseaseR35GM118335 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI JORDE, LYNN · 2016 to 2025
$5.1M
NRSA Training CoreTL1TR002540 · NCATS · UNIVERSITY OF UTAH · PI FAGERLIN, ANGELA, FAIRFAX, KEKE CELESTE · 2018 to 2022
$1.6M
Integrative Genomic Applications to Understand the Etiology of Unsolved Craniofacial AnomaliesR00DE026824 · NIDCR · MASSACHUSETTS GENERAL HOSPITAL · PI BRAND, HARRISON · 2020 to 2022
$747k
Exploring the genetic architecture of structural birth defectsR03HD099547 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2019 to 2020
$336k
NCATS NIH HHS TL1 TR002540NICHD NIH HHS R01 HD081256NICHD NIH HHS R03 HD099547NIDCR NIH HHS R00 DE026824NIGMS NIH HHS R35 GM118335NIMH NIH HHS R01 MH115957
6 · The paper itself

Abstract

Each human genome includes de novo mutations that arose during gametogenesis. While these germline mutations represent a fundamental source of new genetic diversity, they can also create deleterious alleles that impact fitness. Whereas the rate and patterns of point mutations in the human germline are now well understood, far less is known about the frequency and features that impact de novo structural variants (dnSVs). We report a family-based study of germline mutations among 9,599 human genomes from 33 multigenerational CEPH-Utah families and 2,384 families from the Simons Foundation Autism Research Initiative. We find that de novo structural mutations detected by alignment-based, short-read WGS occur at an overall rate of at least 0.160 events per genome in unaffected individuals, and we observe a significantly higher rate (0.206 per genome) in ASD-affected individuals. In both probands and unaffected samples, nearly 73% of de novo structural mutations arose in paternal gametes, and we predict most de novo structural mutations to be caused by mutational mechanisms that do not require sequence homology. After multiple testing correction, we did not observe a statistically significant correlation between parental age and the rate of de novo structural variation in offspring. These results highlight that a spectrum of mutational mechanisms contribute to germline structural mutations and that these mechanisms most likely have markedly different rates and selective pressures than those leading to point mutations.

Indexed as

FamilyGerm CellsMutation RateAgingAutistic DisorderBiasDNA Copy Number VariationsDNA Mutational AnalysisFemaleGenome, HumanGerm-Line MutationHumansMalePaternal AgePoint Mutationautismcopy number variationde novo mutationgenetic diversitygenomicsgenomic structuregermline mutationstructural variation

Identifiers

PMID33675682
PMCPMC8059337
OpenAlexW3135714499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.